Marizyme, Inc. (MRZM) financial statements (2020 and earlier)
Company profile
| Business Address |
2295 TOWNE LAKE PKWY STE 116-290 WOODSTOCK, GA 30189 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 3/31/2018 | 12/31/2017 | 12/31/2012 | 12/31/2011 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 0 | 0 | 0 | 1 | ✕ | |||
| Cash and cash equivalents | 0 | 0 | 0 | 1 | ✕ | |||
| Receivables | 4 | ✕ | ||||||
| Prepaid expense | 0 | 0 | ✕ | ✕ | ||||
| Assets held-for-sale, not part of disposal group | 0 | 0 | ✕ | ✕ | ||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | 0 | ✕ | ||
| Assets held-for-sale | ✕ | ✕ | ✕ | ✕ | 0 | ✕ | ||
| Income taxes receivable | ✕ | ✕ | ✕ | ✕ | 0 | ✕ | ||
| Other undisclosed current assets | 0 | 0 | 0 | ✕ | ||||
| Total current assets: | 0 | 0 | 0 | 6 | ✕ | |||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 0 | ✕ | ||||||
| Long-term investments and receivables | 1 | ✕ | ||||||
| Long-term investments | 0 | ✕ | ||||||
| Accounts and financing receivable, after allowance for credit loss | 0 | ✕ | ||||||
| Intangible assets, net (including goodwill) | 29 | 46 | ✕ | |||||
| Goodwill | 34 | ✕ | ||||||
| Intangible assets, net (excluding goodwill) | 29 | 12 | ✕ | |||||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | ✕ | ✕ | 0 | ✕ | ||
| Assets held-for-sale, long lived | ✕ | ✕ | ✕ | ✕ | 2 | ✕ | ||
| Other undisclosed noncurrent assets | 3 | 3 | 1 | ✕ | ||||
| Total noncurrent assets: | 29 | 3 | 3 | 50 | ✕ | |||
| TOTAL ASSETS: | 29 | 3 | 3 | 57 | ✕ | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 0 | 0 | 6 | ✕ | ||||
| Accounts payable | 0 | ✕ | ||||||
| Other undisclosed accounts payable and accrued liabilities | 0 | 6 | ✕ | |||||
| Debt | 1 | ✕ | ||||||
| Due to related parties | 3 | ✕ | ||||||
| Deferred revenue and credits | ✕ | ✕ | 6 | ✕ | ||||
| Other liabilities | 1 | ✕ | ||||||
| Other undisclosed current liabilities | 1 | 1 | 1 | ✕ | ||||
| Total current liabilities: | 0 | 1 | 1 | 18 | ✕ | |||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 4 | ✕ | ||||||
| Long-term debt, excluding current maturities | 4 | ✕ | ||||||
| Liabilities, other than long-term debt | 0 | ✕ | ||||||
| Pension and other postretirement defined benefit plans, liabilities | ✕ | ✕ | ✕ | ✕ | 0 | ✕ | ||
| Other undisclosed noncurrent liabilities | 0 | ✕ | ||||||
| Total noncurrent liabilities: | 4 | ✕ | ||||||
| Total liabilities: | 0 | 1 | 1 | 22 | ✕ | |||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | 29 | 2 | 2 | 31 | ✕ | |||
| Common stock | 0 | 0 | 0 | 0 | ✕ | |||
| Treasury stock, value | (0) | (0) | (0) | ✕ | ||||
| Additional paid in capital | 58 | 30 | 30 | 0 | ✕ | |||
| Accumulated other comprehensive income (loss) | (0) | (1) | 0 | ✕ | ||||
| Accumulated deficit | (30) | (28) | (27) | (19) | ✕ | |||
| Other additional capital | 0 | 0 | 0 | ✕ | ||||
| Other undisclosed stockholders' equity attributable to parent | 0 | 50 | ✕ | |||||
| Stockholders' equity attributable to noncontrolling interest | 3 | ✕ | ||||||
| Total stockholders' equity: | 29 | 2 | 2 | 35 | ✕ | |||
| TOTAL LIABILITIES AND EQUITY: | 29 | 3 | 3 | 57 | ✕ | |||
Income statement (P&L) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 3/31/2018 | 12/31/2017 | 12/31/2012 | 12/31/2011 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 0 | 0 | 26 | ✕ | |||
| Revenue, net | ✕ | ✕ | 26 | ✕ | |||
| Other income | 0 | ✕ | ✕ | ||||
| Cost of revenue | (0) | (15) | ✕ | ||||
| Cost of goods and services sold | (15) | ✕ | |||||
| Other undisclosed gross profit | (0) | ✕ | |||||
| Gross profit: | 0 | 0 | 11 | ✕ | |||
| Operating expenses | (0) | (0) | (20) | ✕ | |||
| Other operating income (expense), net | (0) | 2 | ✕ | ||||
| Other expenses | (1) | ✕ | |||||
| Other undisclosed operating income (loss) | 0 | (2) | ✕ | ||||
| Operating loss: | (0) | (0) | (8) | ✕ | |||
| Nonoperating expense | (0) | (2) | ✕ | ||||
| Other nonoperating expense | (0) | (1) | ✕ | ||||
| Interest and debt expense | (0) | ✕ | |||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 0 | ✕ | |||||
| Loss from continuing operations before equity method investments, income taxes: | (0) | (0) | (10) | ✕ | |||
| Loss from equity method investments | (0) | ✕ | |||||
| Loss from continuing operations before income taxes: | (0) | (0) | (10) | ✕ | |||
| Income tax expense | (1) | ✕ | |||||
| Loss before gain (loss) on sale of properties: | (0) | (0) | (12) | ✕ | |||
| Other undisclosed net income | 0 | ✕ | |||||
| Net loss: | (0) | (0) | (11) | ✕ | |||
| Other undisclosed net income (loss) attributable to parent | (0) | 5 | ✕ | ||||
| Net loss available to common stockholders, diluted: | (0) | (1) | (7) | ✕ | |||
Comprehensive Income ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 3/31/2018 | 12/31/2017 | 12/31/2012 | 12/31/2011 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (0) | (0) | (11) | ✕ | |||
| Other undisclosed comprehensive loss | (0) | ✕ | |||||
| Comprehensive loss: | (0) | (0) | (11) | ✕ | |||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (0) | ✕ | |||||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 5 | ✕ | |||||
| Comprehensive loss, net of tax, attributable to parent: | (0) | (0) | (7) | ✕ | |||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.